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Commentary
Radiation exposure through drinking water 
results from naturally occurring radionuclides 
in drinking water sources, in particular alpha-
radiation–emitting uranium, radium, and 
their progeny, including radon. According 
to the World Health Organization (WHO), 
when activity concentration in drinking water 
exceeds the recommended level of 0.5 Bq/L 
for gross-α or 1 Bq/L for gross-β activi-
ties [simultaneously measured activity from 
a mixture of natural alpha [uranium-238 
(238U), 234U, thorium-232 (232Th), radium-
226 (226Ra), and polonium-210 (210Po)] and 
beta emitters [228Ra and lead-210 (210Pb)], 
radionuclide-specific concentrations should 
be brought into compliance with WHO guid-
ance levels: 0.1 Bq/L for 228Ra; 1 Bq/L for 
223–226Ra, 234U, and 235U; 10 Bq/L for 238U; 
100Bq/L for radon-222 (222Rn), and 15 µg/L 
for total uranium (WHO 2004).
Ingested radionuclides are absorbed into 
the blood (International Commission on 
Radiological Protection 2007) and accumu-
late in specific tissues that they may damage. 
Of absorbed uranium, 66% is rapidly elimi-
nated via urine, while the rest is distributed 
and stored in the kidney (12–25%), bone 
(10–15%), and soft tissue (Wrenn et al. 
1985). Radium deposits mostly in the bone 
(Wrenn et al. 1985). Ingested radon gas dif-
fuses into the stomach wall, making the stom-
ach wall the tissue most irradiated by ingested 
radon because of its short half-life (3.8 days) 
(Hopke et al. 2000).
Natural uranium induces chemical toxic-
ity, especially nephrotoxicity, which is more 
harmful than radiotoxicity; whereas radium 
and radon are thought to induce solely radio-
toxicity (Wrenn et al. 1985).
Although some epidemiological studies 
have addressed the question of the possible 
health effects after ingesting naturally occur-
ring radionuclides through drinking water 
(Kurttio et al. 2002, 2006a; Mao et al. 1995; 
Selden et al. 2009), their results have not been 
summarized to date. In this commentary we 
discuss available epidemiological findings and 
evidence of possible biological effects.
Synopsis of the Available 
Epidemiological Evidence
We searched the databases PubMed (http://
www.ncbi.nlm.nih.gov/pubmed) and Scopus 
(http://www.info.scopus.com) to identify all 
epidemiological studies dealing with poten-
tial health effects of naturally occurring 
radionuclides in drinking water reported for 
1970–2009. For search terms, we used com-
binations of the key words “health,” “water,” 
and “radioactivity.” The word “health” was 
alternatively replaced by “epidemiology,” 
“case control,” “cohort,” and “cancer.” The 
word “radioactivity” was alternatively replaced 
by the names of the elements occurring in the 
decay chains of interest, namely uranium, 
thorium, protactinium, actinium, polo-
nium, bismuth, radon, thallium, and lead. 
References in each paper were reviewed for 
additional sources. Only relevant articles pub-
lished in English in peer-reviewed journals 
were retained. We identified 27 peer-reviewed 
published reports of original epidemiological 
studies, including studies of uranium, radium, 
and radon (Table 1).
Seven cross-sectional studies evaluated 
uranium in drinking water and individual 
biomarkers of chemotoxicity (urinary albu-
min, creatinine, glucose, phosphate, calcium, 
microglobulins, and enzymes). Overall, they 
reported associations between uranium con-
centrations in drinking water and indicators 
for cytotoxic damage to the proximal tubule 
of the kidney nephron (Selden et al. 2009; 
Zamora et al. 1998, 2009) and alteration of 
the renal absorption function (Kurttio et al. 
2002, 2006a; Selden et al. 2009; Zamora 
et al. 1998, 2009). Another study reported 
a positive association with serum carboxy-
terminal telopeptide, an indicator of bone 
resorption, in males (Kurttio et al. 2005).
When cumulative intake of uranium was 
estimated, null or nonsignificant associa-
tions with the studied biomarkers were found 
(Kurttio et al. 2002, 2006a; Mao et al. 1995). 
This may indicate that long-term uranium 
exposure through drinking water ingestion 
had no effect or that cumulative uranium 
intake based on self-administered question-
naires was not estimated accurately (Kurttio 
et al. 2002, 2006a). Inadequate control of 
confounding and insufficient power could 
also have been a problem.
Cancer was investigated in 10 ecologi-
cal studies in the United States. These studies 
focused on the relationships between uranium, 
radium, or radon concentrations in drinking 
water (either in private wells or community 
supplies), averaged across counties or munici-
palities, and rates of cancer incidence or mor-
tality measured at the same aggregation levels. 
In Iowa, Petersen et al. (1966) found that bone 
cancer mortality rates in people 20–29 and 
60–69 years of age were significantly higher 
in towns with water supplies containing 226Ra 
concentration > 110 mBq/L compared with 
other towns. However, the outcome used for 
Address correspondence to I. Guseva Canu, IRSN/
DRPH/SRBE/LEPID, BP 17, 92262 Fontenay-aux-
Roses, France. Telephone: 33 1 58 35 81 64. Fax: 33 
1 46 57 03 86. E-mail: irina.canu@irsn.fr
We thank the reviewers for their useful comments 
on the manuscript. 
This work was partially funded by the French 
Agency for Development (grant 2009/DTO/EAA/
LB/NF/ID/LC N° 25).
The authors declare they have no actual or 
potential competing financial interests.
Received 17 November 2010; accepted 2 August 
2011.
Health Effects of Naturally Radioactive Water Ingestion: The Need 
for Enhanced Studies
Irina Guseva Canu,1 Olivier Laurent,1 Nathalie Pires,2 Dominique Laurier,1 and Isabelle Dublineau1
1Service de Radiobiologie et Epidémiologie, and 2Service d’Etudes et Expertise en Radioprotection, Institut de Radioprotection et de 
Sûreté Nucléaire, Fontenay-aux-Roses, France
Ba c k g r o u n d: Radiological pollution is a potentially important aspect of water quality. However, 
relatively few studies have been conducted to document its possible health effects.
oB j e c t i v e: In this commentary we discuss available epidemiological findings and related data from 
experimental studies concerning the health effects of naturally radioactive water ingestion.
discussion: Despite modest epidemiological evidence of uranium nephrotoxicity and radium 
effects on bone, available data are not sufficient to quantify the health effects of naturally occur­
ring radionuclides in water. Methodological limitations (exposure measurement methods, control 
for confounding, sample size) affect most studies. Power calculations should be conducted before 
launching new epidemiological studies focusing on late pathological outcomes. Studies based on 
biomarkers of exposure and adverse effects may be helpful but should involve more specific mole­
cules than biomarkers used in previous studies. Experimental data on ingestion of drinking water 
are limited to uranium studies, and there is some disagreement between these studies about the 
nephrotoxicity threshold.
co n c l u s i o n: Further experimental and enhanced epidemiological studies should help to reduce 
uncertainties resulting from dose estimation to dose–response characterization.
key w o r d s : Drinking water, epidemiology, ingestion, natural radioactivity, toxicity. Environ 
Health Perspect 119:1676–1680 (2011).  http://dx.doi.org/10.1289/ehp.1003224 [Online 2 August 
2011]Effects of naturally radioactive drinking water
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 12 | December 2011  1677
the study (deaths due in any way to malig-
nant neoplasm involving bone, based on death 
certificates codes) did not rely on a standard 
definition for bone cancer. Bean et al. (1982) 
examined the incidence of various cancer sites 
in 28 Iowa towns, based on two national can-
cer survey programs. They found increased 
rates of bladder cancer in males, breast cancer 
in females, and lung cancer in both sexes in 
association with increasing 226Ra concentration 
in community water supplies. Bone cancer and 
leukemia were not studied as their rates were 
judged to be too unstable for analysis. In con-
trast, Lyman et al. (1985) specifically focused 
on leukemia incidence in 27 Florida coun-
ties. They reported a strong association with 
the percentage of samples from groundwater 
supplies that showed total radium concentra-
tion exceeding 185 mBq/L in these counties. 
Fuortes et al. (1990) observed a weak and 
non  significant association between leukemia 
incidence and 226Ra concentration in water in 
study participants in 59 Iowa towns.
Ecological studies on radon in drinking 
water exhibit broadly comparable patterns. 
Hess et al. (1983) analyzed cancer incidence 
in Maine counties (based on 1950–1969 
National Cancer Institute statistics) and 
reported associations between average radon 
levels in water supplies and rates of all can-
cers combined as well as respiratory, testis, and 
prostate cancers in the counties. Collman et al. 
(1991) employed a similar approach in North 
Carolina and reported associations with all 
cancers and leukemia mortality in children; 
however, they observed no association in adults 
(Collman et al. 1988). Kjellberg and Wiseman 
(1995) specifically focused on stomach cancer 
incidence and mortality in Pennsylvania and 
significant associations were found, but their 
magnitude was not reported. No information 
about other risk factors for stomach cancer 
(e.g., food habits, smoking) was available.
Four case–control studies estimated asso-
ciations between ingestion of radium via drink-
ing water and bone cancer. Two studies were 
conducted in Wisconsin, based on the same 
cancer registry, over the periods 1979–1989 
(Moss et al. 1995) and 1980–1997 (Guse et al. 
2002); it is not clear whether any cases may 
have been included in both analyses. Moss 
et al. (1995) reported a positive but non-
significant association between osteosarcoma 
incidence and gross-α activity exceeding 330 
mBq/L in county water supplies, whereas 
Guse et al. (2002) reported no association with 
radium levels in drinking water supplies. Two 
case–control studies were conducted on bone 
cancer and 226Ra in water supplies at birthplace 
residences in Ontario, Canada, based on mor-
tality (Finkelstein 1994) and incidence data 
(Finkelstein and Kreiger 1996). The first study 
reported a significant association between mor-
tality for each subtype of bone cancers com-
bined and 226Ra concentration in community 
water supplies or birthplace private wells. Both 
studies reported associations between osteo-
sarcoma and 226Ra birthplace concentrations, 
and a significant association was reported based 




in water Outcome No. of subjects
Mao et al. 1995* Cross-sectional U 19.6 µg/L Biomarkers of renal (glomerular) damage 140 cases
Zamora et al. 1998* Cross-sectional U 100 µg/L Biomarkers of renal (tubular) damage 50 cases
Kurttio et al. 2002* Cross-sectional U 131 µg/L Biomarkers of renal (tubular) damage 325 cases
Kurttio et al. 2005* Cross-sectional U 124 µg/L Biomarkers of renal (tubular) damage 288 cases
Kurttio et al. 2006a Cross-sectional U 25 µg/L Biomarkers of renal (tubular) damage 193 cases
Selden et al. 2009* Cross-sectional U 180 µg/L Biomarkers of renal (tubular) damage 454 cases
Zamora et al. 2009* Cross-sectional U 88 µg/L Biomarkers of renal (tubular) damage 54 cases
Petersen et al. 1966* Ecological 226Ra 170 mBq/L Bone cancer mortality 267 cases
Bean et al. 1982* Ecological 226Ra >110 mBq/L Cancer incidence 1,596 cases
Lyman et al. 1985* Ecological 226Ra >185 mBq/L Leukemia incidence and mortality 873 incident/890 mortality cases
Fuortes et al. 1990* Ecological 226Ra NR Leukemia incidence 700 cases
Hess et al. 1983 Ecological 226Ra NR Cancer incidence 33,928 cases
Collman et al. 1988 Ecological 222Rn NR Cancer mortality Total cancer cases NR (1,758 leukemias)
Collman et al. 1991* Ecological 222Rn NR Cancer mortality 2,706 cases (1,194 leukemias)
Kjellberg and Wiseman 1995* Ecological 222Rn NR Stomach cancer incidence and mortality NR
Cech et al. 2007* Ecological 226Ra > 110 mBq/L Orofacial cleft defect births 167 cases
Cech et al. 2008* Ecological 226Ra > 110 mBq/L Orofacial cleft defect births 300 cases
Moss et al. 1995 Case–control Gross α 300 mBq/L Osteosarcoma incidence 167 cases/989 controls with other cancers, 
matched on age, sex, and race
Guse et al. 2002 Case–control 226+228Ra NR Osteosarcoma incidence 319 osteosarcoma cases/3,198 general population 
controls matched on age, sex, and ZIP code
Finkelstein 1994* Case–control 226Ra 26 mBq/L Bone cancer mortality 283 cases/285 controls (died of any other disease) 
matched on age, sex, and year of death
Finkelstein and Kreiger 1996* Case–control 226Ra 26 mBq/L Bone sarcoma incidence and mortality 583 cases/754 controls with (or died of) any other 
disease matched on age, sex, and year of death 
or diagnosis
Hirunwatthanakul et al. 2006* Case–control 226Ra NR Digestive cancer incidence 32 cases/138 randomly selected healthy controls
Witmans et al. 2008* Case–control U ≈ 1 µg/L Non-Hodgkin lymphoma incidence 88 cases/132 controls matched on age and sex
Seiler 2004 Case–control U ≈ 2 g/L Leukemia incidence 16 wells as cases/100 other community wells as 
controls
Auvinen et al. 2002 Case–cohort U 0.45 Bq/L Leukemia incidence 35 cases/274 controls matched on age and sex
226Ra 30 mBq/L
222Rn 500 Bq/L
Auvinen et al. 2005 Case–cohort U 0.45 Bq/L Stomach cancer incidence 107 cases/371 controls matched on age and sex
226Ra 30 mBq/L
222Rn 500 Bq/L
Kurttio et al. 2006b Case–cohort U 0.45 Bq/L Urinary cancer incidence 112 cases (61 bladder, 51 kidney)/274 controls 
matched on age and sex 226Ra 30 mBq/L
222Rn 500 Bq/L
NR, not reported.
*Statistically significant increase in the health damage of interest. Guseva Canu et al.
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on a combined statistical analysis of the two 
studies (Finkelstein and Kreiger 1996). A sig-
nificant association was also observed for all 
sarcomas. However, in this combined analysis, 
reconstituted (and partly simulated) lifetime 
226Ra exposure estimates were not significantly 
associated with these outcomes.
A case–control study of digestive cancer 
incidence in Thailand reported an associa-
tion with estimated oral radium consumption 
per day, but this was based on only 32 cases 
(Hirunwatthanakul et al. 2006).
In a Saskatchewan, Canada, case–control 
study on non-Hodgkin lymphoma incidence, 
cases had higher uranium concentrations in 
their drinking water than controls (Witmans 
et al. 2008). Seiler (2004), in a case–control 
study of 16 leukemia cases in Fallon, Nevada, 
found no significant differences in well ura-
nium or radon concentration between cases 
and controls.
The only cohort study investigating the 
association between water radioactivity and 
cancer incidence is one of Finnish study sub-
jects using bedrock well water. Authors used 
this cohort to conduct three case–cohort stud-
ies on 107 stomach cancer cases (Auvinen 
et al. 2005), 112 urinary cancer cases (Kurttio 
et al. 2006b), and 35 leukemia cases (Auvinen 
et al. 2002). No significant associations 
were reported, either with radionuclide con-
centrations (uranium, radium, and radon) 
in well water or with cumulative radiation 
doses when estimated (Kurttio et al. 2006b). 
However, each study included a relatively 
small number of cases and therefore had only 
modest statistical power.
Potential reproductive toxicity of radium 
and radon was studied in Harris County, 
Texas. Cech et al. (2007) reported that rates 
of orofacial clefts (based on birth certificates 
over the 1990–1994 period) were signifi-
cantly higher in administrative areas (defined 
by postal code) with 226Ra concentrations 
exceeding 110 mBq/L than in areas with lower 
concentrations. Results were similar when 
the study was repeated in 1999–2002 using 
updated total radium measurements (Cech 
et al. 2008).
Limitations and Uncertainties
Most reviewed studies on natural radioactivity 
in drinking water had important limitations 
with regard to exposure assessment, which 
can bias measures of association. First, dose 
assessment errors can result from sampling 
and analysis of water. In estimating retrospec-
tive cumulative intake, authors have assumed 
constant uranium concentrations in water 
over time, although these actually vary widely 
depending, for instance, on carbon dioxide 
partial pressures, pH of the source aquifer, 
and season (Ribera et al. 1996). Water radio-
nuclides mitigation was considered in one 
study of uranium (Zamora et al. 1998) but 
not of radium, although most were based 
on public water supply measurements, and 
water softening is known to decrease radium 
concentrations substantially (Vesterbacka and 
Salonen 2008). The physicochemical nature 
of the contaminant, that is, determining its 
chemical speciation in water and biological 
fluids, was not accounted for. This might pro-
duce misleading results as some species (e.g., 
calcium-uranyl-carbonato complexes) are not 
cytotoxic, whereas others (e.g., uranium car-
bonate or citrate) are (Prat et al. 2009).
Second, few studies accounted for indi-
vidual water consumption patterns (Auvinen 
et al. 2002; Hirunwatthanakul et al. 2006; 
Kurttio et al. 2006a), and few have considered 
individual residential mobility and changes in 
water supplies over time [e.g., via collection 
of individual residential histories (Finkelstein 
and Kreiger 1996)] although some specifi-
cally selected subjects who did not change 
residences (Auvinen et al. 2002; Kurttio et al. 
2006b). Other studies characterized water 
quality at residential locations either at the 
time of diagnosis or death (Guse et al. 2002) 
or at study subjects’ birthplaces (Finkelstein 
1994). Temporality of exposure assessment 
may also be an issue in cross-sectional studies 
of uranium chemotoxicity. Water and urine 
samples were obtained from participating 
individuals at the same time point, which 
would not allow judging whether exposure 
preceded effects.
A third and closely related issue is that 
most cumulative exposure assessment was 
based on cumulative duration of water con-
sumption, whereas the period during which 
doses are delivered to target organs is a func-
tion of radionuclide intake and retention in 
these organs (i.e., radium or uranium seques-
tered in the bone). Inadequate accounting for 
the retention period may raise a problem of 
classification of the relevant dose and conse-
quently of the dose–response magnitude. This 
is especially true when estimating the effects 
of exposures that occur during exposure win-
dows of high sensitivity, such as fetal or child 
development, because of anatomical and physi-
ological differences (e.g., higher gastrointesti-
nal absorption of radionuclides, higher bone 
formation/  resorption rate). Lack of informa-
tion about individual differences in absorption 
and biokinetics could also lead to bias in the 
  quantification of the relevant dose.
Finally, the latency period between 
  exposure-related initiation and clinical diag-
nosis may be decades for some cancer but 
has not been accounted for (by lagging dose 
estimates) in most studies.
Only two studies (Hirunwatthanakul et al. 
2006; Zamora et al. 1998) considered expo-
sure to radionuclides from sources other than 
drinking water. However, the intake derived 
from food (mostly vegetables, fruit, and grains) 
can be > 80% for total uranium intake and 
about 50% for total radium intake (Wrenn 
et al. 1985). For radon, inhalation of airborne 
radon released from soils or water constitutes 
the major route of exposure (Hopke et al. 
2000), and that particular route has not been 
considered in studies of this radionuclide. 
Further, coexposure to arsenic or terrestrial 
gamma rays, which may be higher in uranium- 
and radon-rich areas (Seiler 2004), was not 
considered in the reviewed studies. Collecting 
more data about individual lifestyle patterns 
(e.g., dietary patterns, smoking) would have 
been useful to assess potential confounding. 
For instance, except for Kurttio et al. (2006a, 
2006b),   smoking was rarely adjusted for 
in studies.
Most of the reviewed studies included 
modest (< 100) numbers of cases (especially for 
specific pathological subgroups (Auvinen et al. 
2002; Seiler 2004), which limited their statisti-
cal power to detect and precisely quantify asso-
ciations between health risks and radiation in 
drinking water. Both study sizes and duration 
of follow-up contributed to this limitation.
Biological Effects and Action 
Mechanisms
The most relevant animal studies on chronic 
drinking water ingestion effects were per-
formed for uranium. Biological effects of 
uranium in kidneys were reported, including 
modifications in renal metabolism of xenobiot-
ics (Souidi et al. 2005), vitamin D homeostasis 
(Tissandié et al. 2007), and iron homeostasis 
(Berradi et al. 2008). Excessive iron accumu-
lation and apoptosis in the tubulo  interstitial 
region and uranium-induced oxidative stress 
were reported (Linares et al. 2006; Taulan 
et al. 2004). Histological lesions of renal tis-
sue were also observed, mainly in the corti-
cal part of the kidneys (Donnadieu-Claraz 
et al. 2007; Gilman et al. 1998; Ortega et al. 
1989). Gilman et al. (1998) reported the low-
est threshold of adverse effects for the kidney 
at 0.03 mg/kg/day, and this threshold was used 
to establish WHO guidelines for uranium in 
drinking water (WHO 2004). In vitro studies 
demonstrated that uranium alters the expres-
sion of genes involved in the cytochromes P450 
and glutamate metabolic pathways, cell signal-
ing and trafficking (Prat et al. 2010; Vietti and 
Lasley 2007), and deregulation of the apop-
totic process (Prat et al. 2010). Experimental 
studies indicated that in vivo tissue effects of 
uranium in kidneys are not always reflected by 
modifications of renal and plasma parameters. 
A few authors have demonstrated modifica-
tions of plasma biochemical parameters, nota-
bly urea and creatinine, despite the absence of 
molecular or histological effects. This may par-
tially explain (along with the methodological 
limitations of epidemiological studies discussed Effects of naturally radioactive drinking water
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above) the modest evidence of renal uranium 
effects observed in human studies. This would 
argue in favor of launching epidemiological 
and experimental studies concurrently, using 
the most appropriate biomarkers of adverse 
effects. Regarding bone, uranium induces 
inhibition of osteoblastic activity, resulting in 
bone volume decrease and healing interfer-
ence (Guglielmotti et al. 1987). In vitro studies 
showed that uranium induces genomic insta-
bility and neoplastic transformation in osteo-
blasts (Miller et al. 1998, 2003) and modifies 
oxidative metabolism and reduces bone for-
mation (Tasat et al. 2007). According to Prat 
et al. (2010), uranium also alters the expression 
of the gene for osteopontin, a candidate bio-
marker of bone resorption and urolithiasis.
Concerning radium, most animal stud-
ies have investigated effects on bone after 
radium injection. Both 226Ra and 228Ra rap-
idly induce changes in bone structure and 
hematopoiesis. Bone sarcomas were found in 
all species tested within a life span follow-up 
[Agency for Toxic Substances and Disease 
Registry (ATSDR) 1990]. Leukemias were 
reported after 224Ra injection (ATSDR 1990). 
The major evidence concerning radium expo-
sure effects come from epidemiological studies 
of radium dial painters (Rowland et al. 1978), 
which indicated a positive dose–response rela-
tionship in humans for bone and head and 
neck sarcomas. Authors concluded that 228Ra 
was about twice as effective at causing bone 
sarcoma as 226Ra, whereas head carcinoma 
was associated only with 226Ra. Radium dial 
painters were not at increased risk of leuke-
mia, which was unexpected given that radium 
accumulation in bone would be expected to 
affect potentially leukemic bone marrow cells. 
Possible explanations include non  uniformity 
of irradiation, lethality in target cells, or a 
low frequency of susceptible target cells in 
irradiated regions. In addition, there was no 
conclusive evidence of increased risks of other 
cancers (Mays et al. 1985).
Experimental studies that reported effects 
of radon-contaminated drinking water are 
very rare (Masse et al. 1992; Sullivan et al. 
1986). Because of this lack of data, large 
uncertainties remain concerning the transit 
time of radon throughout the gastrointesti-
nal tract and whole-body radon retention. 
These uncertainties lead to dose overestima-
tion by greater than two orders of magnitude, 
depending on the model used for dose calcu-
lation (Kendall and Smith 2002).
Conclusion and Perspectives
Despite modest human epidemiological evi-
dence of uranium nephrotoxicity and radium 
bone carcinogenicity, available studies do not 
clearly demonstrate the health effects of radio-
nuclides at levels naturally encountered in 
drinking water. Methodological limitations 
(exposure assessment, possible confounders, 
limited sample size), affecting most reviewed 
studies, should be remedied in future studies.
New prospective cohorts, including poten-
tially sensitive subpopulations (children, preg-
nant women) should be set in geographic 
regions known to have elevated concentration 
of radionuclides in drinking water sources (e.g., 
Finland and Canada for uranium, Iran and 
north-central states of America for radium). 
Exposure and biological effects assessments 
would be more informative if performed within 
the framework of prospective surveys and based 
on biochemical analyses of water (including 
chemical characterization of radionuclide con-
taminant) and individual biological samples 
(urine, blood). For uranium, urinalysis is a gold 
standard for exposure monitoring, whereas 
for radiotoxic contaminants, organ-absorbed 
doses must be assessed to estimate cumulative 
exposure. New experimental data are neces-
sary to resolve uncertainties surrounding transit 
time of radon throughout the gastrointestinal 
tract and whole-body radon retention and thus 
improve precision of internal dose assessment. 
Measurement data should be coupled with 
questionnaires on water and diet consump-
tion patterns. These questionnaires should also 
collect information on all potential risk factors 
for the health outcomes studied (e.g., smoking, 
occupational exposures). Residential mobility 
should be documented via active follow-up 
of individuals. To study cancer, residential 
exposures to radon and gamma rays should be 
measured in each subject’s residence.
Statistical power should be calculated 
before launching epidemiological studies on 
late multifactorial pathological outcomes such 
as cancers. In epidemiological studies look-
ing at biomarkers of subclinical effects, such 
calculations are still feasible but might be less 
accurate because of a lack of data relevant to 
assumptions used to estimate power. Some 
biomarkers of early adverse effect could be 
more sensitive indicators than disease or death; 
therefore, their use in epidemiological studies 
would require fewer subjects. However, most 
currently available biomarkers tend to have low 
sensitivity and specificity as proxy measures 
of adverse effects. According to Adler (2010), 
even the biomarkers considered to be the best 
choices for diagnosing early kidney damage 
(i.e., N-acetyl-β-glucosaminidase, human-
  kidney-injury-molecule-1, cystatine-c, glutathi-
one S-transferase) do not meet all the criteria 
of a desirable biomarker, especially in terms 
of specificity. However, simultaneous use of 
complementary biomarkers can be useful to 
compensate for their respective limitations.
Further research should be conducted to 
identify biomarkers with a better specificity 
and sensitivity for the contaminant and/or 
disease. The time scale of the biomarker, expo-
sure, and outcome to get the best matchup of 
the exposure–dose and dose–response rela-
tionships must be considered. Research must 
also be developed to relate levels of these 
biomarkers to a probability of future disease 
occurrence in order to interpret results from 
studies based on biomarkers of early effects in 
a public health perspective.
Given the extent of these challenging tasks 
and the need for sufficient statistical power to 
detect potentially subtle effects (which might 
have non  -negligible collective impacts in 
view of the large numbers of people exposed), 
sharing of means and expertise from several 
research teams would probably be necessary 
to conduct joint studies. Ideally, this would 
be completed within the framework of inter-
national collaborations.
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